Figure 3.
Overall survival (OS) from diagnosis and time to progression (TTP) for IMWG and R‐ISS stages (patients without ASCT; N = 374)
Overall survival (OS) from diagnosis and time to progression (TTP) for IMWG and R‐ISS stages (patients without ASCT; N = 374)